Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin in Rectal Cancer
NCT00259363Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Oct 2002
- Primary completion
- Jun 2006
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in rectal adenocarcinoma, sponsored by Sanofi. Started Oct 2002; status: terminated.
02
Drugs
oxaliplatin
03
Conditions
rectal adenocarcinoma
Beyond the preview
Go deeper on NCT00259363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00259363.